TerrAscend Corp. (TSX:TSND)
0.8100
0.00 (0.00%)
Aug 14, 2026, 3:59 PM EST
TerrAscend Revenue
TerrAscend had revenue of $67.12M USD in the quarter ending June 30, 2026, with 3.25% growth. This brings the company's revenue in the last twelve months to $263.91M, up 1.15% year-over-year. In the year 2025, TerrAscend had annual revenue of $260.56M, down -2.81%.
Revenue (ttm)
$263.91M
Revenue Growth
+1.15%
P/S Ratio
0.67
Revenue / Employee
$254.25K
Employees
1,038
Market Cap
250.43M CAD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 260.56M | -7.52M | -2.81% |
| Dec 31, 2024 | 268.08M | 17.57M | 7.01% |
| Dec 31, 2023 | 250.51M | 2.68M | 1.08% |
| Dec 31, 2022 | 247.83M | 53.62M | 27.61% |
| Dec 31, 2021 | 194.21M | 62.06M | 46.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cresco Labs | 924.67M |
| Aurora Cannabis | 314.07M |
| Organigram Global | 309.18M |
| Auxly Cannabis Group | 158.57M |
| Medexus Pharmaceuticals | 146.70M |
| Cannara Biotech | 117.33M |
| HLS Therapeutics | 79.87M |
| Cipher Pharmaceuticals | 70.47M |
TerrAscend News
- 8 days ago - TerrAscend Earnings Call Transcript: Q2 2026 - Transcripts
- 8 days ago - TerrAscend Earnings release: Q2 2026 - Filings
- 8 days ago - TerrAscend Slides: Q2 2026 - Filings
- 8 days ago - TerrAscend Registration statement: Q2 2026 - Filings
- 21 days ago - 3 Top Marijuana Stocks For Investors To Know About Before The Next Run - MarijuanaStocks
- 4 weeks ago - TerrAscend to Host Second Quarter 2026 Earnings Conference Call - GlobeNewsWire
- 6 weeks ago - TerrAscend Signs Agreement to Acquire Fifth Dispensary in New Jersey - GlobeNewsWire
- 6 weeks ago - TerrAscend Files Preliminary Proxy Statement for Special Meeting of Shareholders in Preparation for Uplisting to US Exchange - GlobeNewsWire